ACT Enact (ACT) Insider Trading, Ownership & Congress Trades
Insurance · Insurance agents, brokers & service · CIK 0001823529
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
139
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · no price filed
What the filings say about ACT
Insiders, 180 days
-$172.3M net sold
3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$991.7K
1 notice
Enact insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Enact Holdings, Inc. insiders sold a net $172.3M of stock across 77 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 44 earlier Form 4 trades (code P or S) here by this insider (44 sales), the last on Aug 31, 2026.
- The trade is 0.7% of the 109,628,073 shares held after it.
- No other insider sold within 30 days.
- 139 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Genworth Holdings, Inc. sold about $37.1M of ACT on Sep 30, 2026, the largest insider sale at the company since 2021; 139 funds added in the latest 13F quarter.Context
- 43 earlier Form 4 trades (code P or S) here by this insider (43 sales), the last on Jul 31, 2026.
- The trade is 0.6% of the 110,390,967 shares held after it.
- 1 other insider sold within 30 days.
- 139 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Genworth Holdings, Inc. sold about $34.0M of ACT on Aug 31, 2026; 1 other insider sold within 30 days and 139 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Mar 4, 2025.
- The trade is 62.6% of the 32,003 shares held after it.
- 1 other insider sold within 30 days.
- 139 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Gen. Counsel & Secretary Stolove Evan sold about $991.7K of ACT on Aug 17, 2026; 1 other insider sold within 30 days and 139 funds added in the latest 13F quarter.Context
- 42 earlier Form 4 trades (code P or S) here by this insider (42 sales), the last on Jun 30, 2026.
- The trade is 0.5% of the 111,078,346 shares held after it.
- 1 other insider sold within 30 days.
- 139 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Genworth Holdings, Inc. sold about $24.0M of ACT on Jul 31, 2026; 1 other insider sold within 30 days and 139 funds added in the latest 13F quarter.Context
- 41 earlier Form 4 trades (code P or S) here by this insider (41 sales), the last on May 29, 2026.
- The trade is 0.5% of the 111,601,572 shares held after it.
- 1 other insider sold within 30 days.
- 139 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Genworth Holdings, Inc. sold about $25.6M of ACT on Jun 30, 2026; 1 other insider sold within 30 days and 139 funds added in the latest 13F quarter.77 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$172.3M over 180 days
-$96.1M over 90 days · -$170.4M of it by a 10%+ holder
below 97% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
139 funds bought in last quarter
below 54% of Insurance
Revenue
+2.8% year over year
below 72% of Insurance
Margin
54.6% net margin
more than 92% of Insurance
Buybacks
$186.5M repurchased, FY to 2026-06-30
more than 53% of Insurance
Short interest
10.1% of the float short (float per yahoo 2026-10-26) · 6.3 days to cover · settled 2026-09-30
below 73% of Insurance
What changed in the last 30 days
Oct 1Insider Genworth Holdings, Inc. sold $37.1M (Sep 30)
Watch ACT
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+34.8%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ACT: institutional holders (13F)
13F holdings, latest reported quarter
4,780,711 sh
$218.5M
3,108,626 sh
$142.1M
1,758,792 sh
$80.4M
1,622,555 sh
$74.2M
1,298,718 sh
$59.4M
Congress trades in ACT
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ACT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Stolove Evan
Filed 2026-08-17
$991.7K
ACT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Royce Small-Cap Value Fund
$1.9M position · as of 2026-06-30
1.7%
Royce Capital Fund - Small-Cap Portfolio
$3.1M position · as of 2026-06-30
1.7%
Keeley Gabelli SMID Cap Value Fund
$319.0K position · as of 2026-06-30
1.3%
Keeley Gabelli Small Cap Dividend Fund
$3.6M position · as of 2026-06-30
1.3%
DWS Global Small Cap Fund
$2.2M position · as of 2026-07-31
1.1%
Cambria Micro and SmallCap Shareholder Yield ETF
$346.0K position · as of 2026-07-31
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Rohit Gupta
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.9M
$22.9M
$1.7M
+139%
+86%
2024
$10.0M
$19.0M
$1.8M
+91%
+55%
2023
$8.1M
$13.9M
$1.7M
+67%
+33%
2022
$7.9M
$9.5M
$1.7M
+32%
-9%
2021
$11.0M
$14.1M
$1.9M
+7%
-1%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $172.3M sold by insiders over 180 days, 139 funds added last quarter, $991.7K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ACT financials
Revenue growth
+2.8%
XBRL, annual
Net margin
54.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ACT
| FY Dec 2025 | $1.2B |
| FY Dec 2024 | $1.2B |
| FY Dec 2023 | $1.2B |
| FY Dec 2022 | $1.1B |
| FY Dec 2021 | $1.1B |
| Jun 2026 | $317.3M |
| Mar 2026 | $312.1M |
| Dec 2025 | $312.7M |
| Sep 2025 | $311.5M |
| Jun 2025 | $304.9M |
| Mar 2025 | $306.8M |
| Dec 2024 | $301.8M |
| Sep 2024 | $309.6M |
At each fiscal year end
Single quarter
Net margin, TTM
+52.7%
net income over revenue, 2021-07-01 to 2022-06-30
Net margin, TTM ACT
| FY Dec 2025 | +53.4% |
| FY Dec 2024 | +54.9% |
| FY Dec 2023 | +57.2% |
| FY Dec 2022 | +60.3% |
| FY Dec 2021 | +48.9% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM ACT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.18x
long-term debt only, 2022-06-30; equity 2022-06-30
Debt to equity ACT
| FY Dec 2025 | 0.18x |
| FY Dec 2024 | 0.18x |
| FY Dec 2023 | 0.18x |
| FY Dec 2022 | 0.18x |
| FY Dec 2021 | 0.18x |
| Jun 2026 | 0.18x |
| Mar 2026 | 0.18x |
| Dec 2025 | 0.18x |
| Sep 2025 | 0.18x |
| Jun 2025 | 0.18x |
| Mar 2025 | 0.18x |
| Dec 2024 | 0.18x |
| Sep 2024 | 0.18x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.97x
TTM operating cash flow over long-term debt only, 2022-06-30
Cash flow to debt ACT
| FY Dec 2025 | 0.98x |
| FY Dec 2024 | 0.93x |
| FY Dec 2023 | 0.85x |
| FY Dec 2022 | 0.76x |
| FY Dec 2021 | 0.77x |
| Jun 2026 | 0.97x |
| Mar 2026 | 0.97x |
| Dec 2025 | 0.98x |
| Sep 2025 | 0.95x |
| Jun 2025 | 0.94x |
| Mar 2025 | 0.98x |
| Dec 2024 | 0.93x |
| Sep 2024 | 0.96x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.2%
TTM net income over average of 2021-06-30 and 2022-06-30
Return on equity ACT
| FY Dec 2025 | +16.2% |
| FY Dec 2024 | +16.2% |
| FY Dec 2023 | +16.2% |
| FY Dec 2022 | +16.2% |
| FY Dec 2021 | +13.7% |
| Jun 2026 | +16.2% |
| Mar 2026 | +16.2% |
| Dec 2025 | +16.2% |
| Sep 2025 | +16.2% |
| Jun 2025 | +16.2% |
| Mar 2025 | +16.2% |
| Dec 2024 | +16.2% |
| Sep 2024 | +16.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.5%
TTM net income over ending balance 2022-06-30
Return on assets ACT
| FY Dec 2025 | +11.5% |
| FY Dec 2024 | +11.5% |
| FY Dec 2023 | +11.5% |
| FY Dec 2022 | +11.5% |
| FY Dec 2021 | +9.5% |
| Jun 2026 | +11.5% |
| Mar 2026 | +11.5% |
| Dec 2025 | +11.5% |
| Sep 2025 | +11.5% |
| Jun 2025 | +11.5% |
| Mar 2025 | +11.5% |
| Dec 2024 | +11.5% |
| Sep 2024 | +11.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ACT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ACT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.17x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ACT
| FY Dec 2025 | 8.79x |
| FY Dec 2024 | 7.39x |
| FY Dec 2023 | 7.01x |
| FY Dec 2022 | 5.60x |
| FY Dec 2021 | 6.15x |
| Jun 2026 | 9.62x |
| Mar 2026 | 8.85x |
| Dec 2025 | 8.79x |
| Sep 2025 | 8.81x |
| Jun 2025 | 8.44x |
| Mar 2025 | 7.81x |
| Dec 2024 | 7.39x |
| Sep 2024 | 8.45x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$6.9B
market value at close 2026-10-26 on 2026-08-03 shares, plus long-term debt only, 2022-06-30, minus cash 2026-06-30
Enterprise value ACT
| FY Dec 2025 | $5.9B |
| FY Dec 2024 | $5.1B |
| FY Dec 2023 | $4.7B |
| FY Dec 2022 | $4.2B |
| FY Dec 2021 | $3.7B |
| Jun 2026 | $6.7B |
| Mar 2026 | $6.0B |
| Dec 2025 | $5.9B |
| Sep 2025 | $5.9B |
| Jun 2025 | $5.7B |
| Mar 2025 | $5.4B |
| Dec 2024 | $5.1B |
| Sep 2024 | $5.7B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield ACT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.28x
P/E over trailing EPS growth of 8%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ACT
| FY Dec 2025 | 2.96x |
| FY Dec 2024 | 1.17x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.20x |
| FY Dec 2021 | n/a |
| Jun 2026 | 1.21x |
| Mar 2026 | 2.46x |
| Dec 2025 | 2.96x |
| Sep 2025 | 7.58x |
| Jun 2025 | 1.53x |
| Mar 2025 | 0.79x |
| Dec 2024 | 1.17x |
| Sep 2024 | 1.21x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.1B |
| Net income | $674.2M | $688.1M | $665.5M | n/a |
| EPS (diluted) | 4.52 | 4.37 | 4.11 | 4.31 |
| Operating cash flow | $724.5M | $686.3M | $632.0M | $560.5M |
| Cash | $582.5M | $599.4M | $615.7M | $513.8M |
| Long-term debt | $744.5M | $743.0M | $745.4M | $742.8M |
| Buybacks | $382.4M | $244.0M | $87.8M | $1.5M |
| Dividends paid | $120.8M | $111.7M | $213.0M | $250.8M |
SEC XBRL, fiscal years, as known on 2026-10-27
ACT Stock Sonar score 6/7 axes
Find similar shapesCompareACT ranks highest on profitability (76th percentile) and financial health (68th), and lowest on insider conviction (1st), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ACT filings, in plain words
Are Enact insiders buying or selling ACT?
In the 180 days to 2026-10-27, Enact insiders were net sellers, a net $172.3M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of ACT?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $991.7K of stock; the latest, by Stolove Evan, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-27, Enact insiders were net sellers of ACT, a net $172.3M across purchases and sales reported on Form 4 by 3 sellers. Most of that figure, $170.4M, came from a holder of 10% or more rather than an officer or director. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $991.7K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
